{"id":316392,"date":"2026-10-19T12:24:09","date_gmt":"2026-10-19T06:54:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316392"},"modified":"2026-10-19T12:24:09","modified_gmt":"2026-10-19T06:54:09","slug":"largecap-mumbai-based-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/","title":{"rendered":"3 Largecap Mumbai-based Stocks to Watch for Future Multibagger Potential: Reliance, Hindustan Unilever and Sun Pharma"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Reliance Rs 1,211.20. Hindustan Unilever Rs 1,893.80. Sun Pharma Rs 1,758.80. Market caps from Rs 4.22 lakh crore to Rs 15.91 lakh crore. Data as of 16 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Reliance, Hindustan Unilever and Sun Pharma are the 3 picks in this Mumbai-based stocks watchlist, with market caps between Rs 4.22 lakh crore and Rs 15.91 lakh crore. Reliance stands out for the lowest PE of the group at 18.05, while Hindustan Unilever offers the highest return on equity at 22.41%. PE ratios run from 18.05 to 34.86, so compare each one with its industry PE before investing. All figures are as of 16 October 2026.<\/p>\n<\/p><\/div>\n<p>Mumbai-based stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Reliance, Hindustan Unilever and Sun Pharma meet that test, with market caps from Rs 4.22 lakh crore to Rs 15.91 lakh crore and Reliance offering the lowest PE of the group at 18.05. Mumbai is home to India&#8217;s largest conglomerate, a leading pharma maker and the country&#8217;s biggest consumer goods company.<\/p>\n<p>This list covers listed companies headquartered in Mumbai with complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening Mumbai-based stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 16 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=mumbai-based-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#What_Are_Mumbai-based_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Mumbai-based Stocks and Why Do They Attract Multibagger Interest?\">What Are Mumbai-based Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Mumbai-based_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Mumbai-based Stocks at a Glance: Price, Market Cap, PE and ROE\">Mumbai-based Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Reliance_Profit_Compounding_at_963_a_Year\" title=\"Reliance: Profit Compounding at 9.63% a Year\">Reliance: Profit Compounding at 9.63% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Hindustan_Unilever_Return_on_Equity_of_2241\" title=\"Hindustan Unilever: Return on Equity of 22.41%\">Hindustan Unilever: Return on Equity of 22.41%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Mumbai-based_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Mumbai-based Stocks: Financial Comparison on Growth and Margins\">Mumbai-based Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Reliance_Hindustan_Unilever_and_Sun_Pharma\" title=\"Institutional Holding in Reliance, Hindustan Unilever and Sun Pharma\">Institutional Holding in Reliance, Hindustan Unilever and Sun Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Mumbai-based_Stocks\" title=\"Risks to Weigh in Mumbai-based Stocks\">Risks to Weigh in Mumbai-based Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Mumbai-based_Stocks\" title=\"How to Choose Between Mumbai-based Stocks\">How to Choose Between Mumbai-based Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Mumbai-based_Stocks_to_Watch\" title=\"Frequently Asked Questions on Mumbai-based Stocks to Watch\">Frequently Asked Questions on Mumbai-based Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Which_are_the_best_Mumbai-based_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best Mumbai-based stocks to watch for multibagger potential?\">Which are the best Mumbai-based stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Is_Hindustan_Unilever_a_good_stock_for_long-term_investors\" title=\"Is Hindustan Unilever a good stock for long-term investors?\">Is Hindustan Unilever a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Reliance_Hindustan_Unilever_and_Sun_Pharma\" title=\"What is the market cap of Reliance, Hindustan Unilever and Sun Pharma?\">What is the market cap of Reliance, Hindustan Unilever and Sun Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_Mumbai-based_stocks\" title=\"What are the risks of investing in Mumbai-based stocks?\">What are the risks of investing in Mumbai-based stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#Is_Reliance_trading_below_its_industry_PE\" title=\"Is Reliance trading below its industry PE?\">Is Reliance trading below its industry PE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-mumbai-based-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Reliance_Hindustan_Unilever_and_Sun_Pharma\" title=\"How much do institutions hold in Reliance, Hindustan Unilever and Sun Pharma?\">How much do institutions hold in Reliance, Hindustan Unilever and Sun Pharma?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Mumbai-based_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Mumbai-based Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mumbai-based stocks are shares of companies headquartered in India&#8217;s financial capital. They include an energy and retail conglomerate, a global pharma company and a household goods leader.<\/p>\n<p>Each is a market leader in its field, with a wide customer base and strong cash flows. Companies with steady growth, strong brands and regular dividends are the ones investors compare in Mumbai-based stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mumbai-based_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Mumbai-based Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 16 October 2026. Reliance has the lowest PE of the group at 18.05, while Hindustan Unilever posts the highest return on equity at 22.41%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/reliance\/reliance-industries-ltd-share-price-today\">Reliance Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,211.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15,91,358<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.11<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.44<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,152.20 to 1,611.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hindunilvr\/hindustan-unilever-ltd-share-price-today\">Hindustan Unilever<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,893.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,45,717<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.77<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.41%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.03<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,814.40 to 2,667.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,758.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,22,427<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.86<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Reliance_Profit_Compounding_at_963_a_Year\"><\/span><strong>Reliance: Profit Compounding at 9.63% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reliance Industries spans oil-to-chemicals, retail, digital services through Jio and a growing new energy business. It reported FY26 revenue of Rs 10,86,181 crore, up 10.53% year on year, and net profit of Rs 95,610 crore, up 18.35%. Net profit has compounded at 9.63% a year since FY22, while revenue has grown 11.18% a year. Operating margin was 17.68% in FY26. The debt-to-equity ratio is 0.44.<\/p>\n<p>Revenue for the June 2026 quarter rose 20.26% to Rs 3,46,807 crore, at an operating margin of 15.89%. Domestic institutions raised their holding from 19.80% in June 2025 to 21.19% in June 2026. The stock trades at a PE of 18.05 against an industry PE of 15.11.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hindustan_Unilever_Return_on_Equity_of_2241\"><\/span><strong>Hindustan Unilever: Return on Equity of 22.41%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hindustan Unilever is India&#8217;s largest FMCG company, with brands across home care, beauty and personal care, and foods. It reported FY26 revenue of Rs 65,219 crore, up 1.69% year on year, and net profit of Rs 10,652 crore. Revenue has compounded at 5.47% a year since FY22. Operating margin was 24.49% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 29.77 against an industry PE of 34.68, below the sector average, with a return on equity of 22.41%. The dividend yield is 2.16%. Revenue for the June 2026 quarter rose 9.84% to Rs 17,529 crore, at an operating margin of 23.63%. Domestic institutions raised their holding from 16.07% in June 2025 to 16.99% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.86 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mumbai-based_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Mumbai-based Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these Mumbai-based stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Reliance<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10,86,181<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">95,610<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Hindustan Unilever<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">65,219<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10,652<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.75%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these Mumbai-based stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Reliance_Hindustan_Unilever_and_Sun_Pharma\"><\/span><strong>Institutional Holding in Reliance, Hindustan Unilever and Sun Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these Mumbai-based stocks alongside the promoter. The table uses the latest reported quarter for each. Reliance has the deepest institutional backing, with FII and DII together holding 38.39% as of June 2026. Domestic institutions increased their holding over the past year in Reliance (from 19.80% to 21.19%), Hindustan Unilever (from 16.07% to 16.99%) and Sun Pharma (from 20.23% to 22.27%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Reliance<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">50.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.20%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Hindustan Unilever<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61.90%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.50%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.99%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.61%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Mumbai-based_Stocks\"><\/span><strong>Risks to Weigh in Mumbai-based Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with Mumbai-based stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Each company follows its own cycle, from energy prices to drug pricing.<\/li>\n<li>Large caps can move slowly in strong markets.<\/li>\n<li><strong>Valuation:<\/strong> Reliance trades at a PE of 18.05 against an industry PE of 15.11, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 3 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Mumbai-based_Stocks\"><\/span><strong>How to Choose Between Mumbai-based Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from Mumbai-based stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (15.11 to 36.42) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track revenue growth, the operating margin and the dividend payout in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Reliance, Hindustan Unilever and Sun Pharma live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among Mumbai-based stocks, Reliance stands out for the lowest PE of the group at 18.05, Hindustan Unilever for the highest return on equity at 22.41% and Sun Pharma for the fastest profit growth, 35.75% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing Mumbai-based stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Mumbai-based_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Mumbai-based Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_Mumbai-based_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best Mumbai-based stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Reliance, Hindustan Unilever and Sun Pharma are the 3 names this list highlights, with market caps of Rs 15,91,358 crore, Rs 4,45,717 crore and Rs 4,22,427 crore respectively. Reliance is notable for the lowest PE of the group at 18.05. Hindustan Unilever stands out for the highest return on equity at 22.41%. Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. These are watchlist names for Mumbai-based stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Hindustan_Unilever_a_good_stock_for_long-term_investors\"><\/span><strong>Is Hindustan Unilever a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hindustan Unilever has a return on equity of 22.41%, a PE of 29.77 against an industry PE of 34.68 and a market cap of Rs 4,45,717 crore. FY26 revenue rose 1.69%, and June 2026 quarter revenue grew 9.84%. Long-term returns in Mumbai-based stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in Mumbai-based stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Reliance_Hindustan_Unilever_and_Sun_Pharma\"><\/span><strong>What is the market cap of Reliance, Hindustan Unilever and Sun Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 16 October 2026, Reliance has a market cap of Rs 15,91,358 crore, Hindustan Unilever has a market cap of Rs 4,45,717 crore and Sun Pharma has a market cap of Rs 4,22,427 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on Mumbai-based stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_Mumbai-based_stocks\"><\/span><strong>What are the risks of investing in Mumbai-based stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are commodity price swings, export drug pricing and consumer demand. Companies with varied businesses and strong brands handle these better. Reliance trades at a PE of 18.05 against an industry PE of 15.11, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Reliance_trading_below_its_industry_PE\"><\/span><strong>Is Reliance trading below its industry PE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Reliance trades at a PE of 18.05 against an industry PE of 15.11. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 9.63% a year since FY22 and FY26 revenue rose 10.53%) and balance sheet strength before drawing a conclusion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Reliance_Hindustan_Unilever_and_Sun_Pharma\"><\/span><strong>How much do institutions hold in Reliance, Hindustan Unilever and Sun Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 38.39% of Reliance (17.20% and 21.19%), 26.49% of Hindustan Unilever (9.50% and 16.99%) and 36.63% of Sun Pharma (14.36% and 22.27%). Rising institutional holding is a useful signal in Mumbai-based stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best Mumbai-based stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reliance, Hindustan Unilever and Sun Pharma are the 3 names this list highlights, with market caps of Rs 15,91,358 crore, Rs 4,45,717 crore and Rs 4,22,427 crore respectively. Reliance is notable for the lowest PE of the group at 18.05. Hindustan Unilever stands out for the highest return on equity at 22.41%. Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. These are watchlist names for Mumbai-based stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Hindustan Unilever a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hindustan Unilever has a return on equity of 22.41%, a PE of 29.77 against an industry PE of 34.68 and a market cap of Rs 4,45,717 crore. FY26 revenue rose 1.69%, and June 2026 quarter revenue grew 9.84%. Long-term returns in Mumbai-based stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in Mumbai-based stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Reliance, Hindustan Unilever and Sun Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 16 October 2026, Reliance has a market cap of Rs 15,91,358 crore, Hindustan Unilever has a market cap of Rs 4,45,717 crore and Sun Pharma has a market cap of Rs 4,22,427 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on Mumbai-based stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in Mumbai-based stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are commodity price swings, export drug pricing and consumer demand. Companies with varied businesses and strong brands handle these better. Reliance trades at a PE of 18.05 against an industry PE of 15.11, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Is Reliance trading below its industry PE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reliance trades at a PE of 18.05 against an industry PE of 15.11. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 9.63% a year since FY22 and FY26 revenue rose 10.53%) and balance sheet strength before drawing a conclusion.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Reliance, Hindustan Unilever and Sun Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 38.39% of Reliance (17.20% and 21.19%), 26.49% of Hindustan Unilever (9.50% and 16.99%) and 36.63% of Sun Pharma (14.36% and 22.27%). Rising institutional holding is a useful signal in Mumbai-based stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>3 largecap Mumbai-based stocks compared on market cap, PE, ROE, growth and institutional holding: Reliance, Hindustan Unilever and Sun Pharma.<\/p>\n","protected":false},"author":33,"featured_media":316391,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13343,13342],"class_list":["post-316392","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-mumbai-based-sector","tag-mumbai-based-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["316391"],"rank_math_title":["Mumbai-based Stocks 2026: Reliance, Hindustan Unilever"],"rank_math_description":["Mumbai-based stocks to watch for multibagger potential: Reliance, Hindustan Unilever and Sun Pharma. Compare market cap, PE, ROE, growth and institutional holding."],"rank_math_focus_keyword":["Mumbai-based stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-largecap-mumbai-based-stocks-to-watch-for-future-multibagger-potential.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=316392"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316392\/revisions"}],"predecessor-version":[{"id":316394,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316392\/revisions\/316394"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/316391"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=316392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=316392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=316392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}